OCLN and metabolic dysfunction-associated steatotic liver disease: In the murine model of non‐alcoholic fatty liver disease (NAFLD), tryptophan supplementation (0.24% wt/wt) reversed the occludin expression in the jejunum and improved the disease‐related liver parameters (Ritze, Bardos, Hubert, Bohle, & Bischoff, 2014).